RT Journal Article
SR Electronic
T1 Investigation of Autosomal Genetic Sex Differences in Parkinson’s disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.09.21250262
DO 10.1101/2021.02.09.21250262
A1 Cornelis Blauwendraat
A1 Hirotaka Iwaki
A1 Mary B. Makarious
A1 Sara Bandres-Ciga
A1 Hampton Leonard
A1 Francis P. Grenn
A1 Julie Lake
A1 Lynne Krohn
A1 Manuela Tan
A1 Jonggeol Jeff Kim
A1 Jesse Raphael Gibbs
A1 Dena G. Hernandez
A1 Jennifer A. Ruskey
A1 Lasse Pihlstrøm
A1 Mathias Toft
A1 Jacobus J. van Hilten
A1 Johan Marinus
A1 Claudia Schulte
A1 Kathrin Brockmann
A1 Manu Sharma
A1 Ari Siitonen
A1 Kari Majamaa
A1 Johanna Eerola-Rautio
A1 Pentti J. Tienari
A1 Donald Grosset
A1 Suzanne Lesage
A1 Jean-Christophe Corvol
A1 Alexis Brice
A1 Nick Wood
A1 John Hardy
A1 Ziv Gan-Or
A1 Peter Heutink
A1 Thomas Gasser
A1 Huw Morris
A1 Alastair J. Noyce
A1 Mike A. Nalls
A1 Andrew B. Singleton
A1 on behalf of the International Parkinson’s Disease Genomics Consortium (IPDGC)
YR 2021
UL http://medrxiv.org/content/early/2021/02/12/2021.02.09.21250262.abstract
AB Parkinson’s disease (PD) is a complex neurodegenerative disorder. Males are on average ∼1.5 times more likely to develop PD compared to females. Over the years genome-wide association studies (GWAS) have identified numerous genetic risk factors for PD, however it is unclear whether genetics contribute to disease etiology in a sex-specific manner.In an effort to study sex-specific genetic factors associated with PD, we explored two large genetic datasets from the International Parkinson’s Disease Genomics Consortium and the UK Biobank consisting of 13,020 male PD cases, 7,936 paternal proxy cases, 89,660 male controls, 7,947 female PD cases, 5,473 maternal proxy cases and 90,662 female controls. We performed GWAS meta-analyses to identify distinct patterns of genetic risk contributing to disease in male versus female PD cases.In total 19 genome-wide significant regions were identified, and no sex-specific effects were observed. A high genetic correlation between the male and female PD GWASes was identified (rg=0.877) and heritability estimates were identical between male and female PD cases (∼20%).We did not detect any significant genetic differences between male or female PD cases. Our study does not support the notion that common genetic variation on the autosomes could explain the difference in prevalence of PD between males and females at least when considering the current sample size under study. Further studies are warranted to investigate the genetic architecture of PD explained by X and Y chromosomes and further evaluate environmental effects that could potentially contribute to PD etiology in male versus females.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Intramural Research Programs of the National Institute on Aging (NIA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participants clinical information and genetic samples were obtained with appropriate written consent and local institutional and ethical approval. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Additionally, our project is covered by all relevant, local IRBs from which the data were derived. All data were de-identified prior to sharing with researchers, and therefore, researchers did not have access to any information on the included subjects. As a result, our study design was reviewed by the NIH Office of IRB Operations, and the reviewing body determined that the research activities did not require IRB approval or review. UK Biobank data were obtained under the application number 33601.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll summary statistics are available at https://pdgenetics.org/resources. Six summary statistics tables are made available: 1) Male PD GWAS (all data), 2) Female PD GWAS (all data), 3) Male PD GWAS (no UKB proxy data), 4) Female PD GWAS (no UKB proxy data), 5) Male PD GWAS (no UKB data) and 6) Female PD GWAS (no UKB data). All code used has been made available on GitHub: https://github.com/neurogenetics/Autosomal-sex-differences-PDv2. https://pdgenetics.org/resources https://github.com/neurogenetics/Autosomal-sex-differences-PDv2